Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
20:00
Spider-Man: Brand New Day generated $1.05 billion in the first six days, becoming the second fastest grossing film after Avengers: Endgame
19:50
Timișoara and Oradea reduce public lighting to save energy
19:50
ISU Buzău intervenes to extinguish a wildfire in the commune of Podgoria, affecting 20 hectares
19:46
Traffic is blocked on DN 1, in the locality of Unirea, due to an accident between a car and a diesel tanker.
19:43
The Commission checks whether Spain can pay the compensation of 23.5 million euros granted to an investor in renewable energy.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
